Table 2.
Effect of PSK on cell cycle distribution of tumor cell lines.
| Tumour cell line | Cell cycle distribution (%) | |||
| SUB-G1 | G2 | S | G1 | |
| AGS control | 5.12 | 16.20 | 31.10 | 32.20 |
| AGS PSK | 12.23 | 14.10 | 0 | 60.80 |
| Ando-2 | 6.35 | 18.12 | 32.25 | 33.46 |
| Ando-2 PSK | 12.40 | 16.30 | 4.35 | 60.10 |
| A549 control | 7.25 | 15.53 | 31.15 | 30.67 |
| A549 PSK | 11.95 | 13.13 | 5.20 | 49.45 |
| B16 control | 8.35 | 12.25 | 30.23 | 31.45 |
| B16 PSK | 14.35 | 8.35 | 5.45 | 55.67 |
| Jurkat control | 8.23 | 18.60 | 32.35 | 25.50 |
| Jurkat PSK | 11.30 | 18.35 | 15.25 | 45.35 |
| HELA control | 5.58 | 16.35 | 21.12 | 44.67 |
| HELA PSK | 10.57 | 9.56 | 14.78 | 51.56 |
| B9 | 5.20 | 12.60 | 20.54 | 49.15 |
| B9 PSK | 6.56 | 6.96 | 15.14 | 63.17 |
Results are for one typical experiment out of three performed.